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Abstract 
 
Background: In the past two decades, a number of studies investigating the role of the therapeutic 
alliance in drug treatment have been published and it is timely that their findings are brought together in a 
comprehensive review.  
Aims: This paper has two principal aims: 1) to assess the degree to which the relationship between drug 
user and counsellor predicts treatment outcome and 2) to critically examine the evidence on determinants 
of the quality of the alliance. 
Method: Peer reviewed research located using the literature databases Medline, PsycInfo and Ovid Full 
Text Mental Health Journals using predefined search-terms and published in the past 20 years is 
considered. Further papers were identified from the bibliographies of relevant publications.  
Findings: A key finding is that the early therapeutic alliance appears to be a consistent predictor of 
engagement and retention in drug treatment. With regard to other treatment outcomes, the early alliance 
appears to influence early improvements during treatment, but it is an inconsistent predictor of post-
treatment outcomes. There is relatively little research on the determinants of the alliance. In studies that 
are available, clients’ demographic or diagnostic pre-treatment characteristics did not appear to predict 
the therapeutic alliance, whereas modest but consistent relationships were reported for motivation, 
treatment readiness and positive previous treatment experiences. 
Conclusions: The therapeutic alliance plays an important role in predicting drug treatment process 
outcomes, but too little is known about what determines the quality of the relationship between drug users 
and counsellors.  
 
Keywords: Review, alliance, retention, treatment outcomes 
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Introduction 
 
The quality of the therapeutic relationship is a significant predictor of psychotherapy and counselling 
outcomes in clients presenting with a variety of non-psychotic disorders across different treatment 
modalities (Horvath and Symonds 1991; Martin et al. 2000) and the therapeutic alliance is seen as an 
essential ingredient of any psychotherapy and counselling (Gaston 1990) Several reviews on the 
therapeutic alliance in generic psychotherapy or counselling settings have already been carried out 
covering a range of issues including the historical and conceptual dimensions of the alliance (Horvath and 
Luborsky 1993), definition of the concept, measurement issues and the relationship between the alliance 
and psychotherapy outcomes (Horvath and Symonds 1991; Marziali and Alexander 1991; Martin, Garske 
et al. 2000), therapy characteristics and techniques (Ackerman and Hilsenroth 2003), the impact of the 
alliance on outcomes in short term dynamic therapy (Crits-Christoph and Connolly 1999), as well as the 
role of the alliance in behaviour therapy (Sweet 1984) and cognitive therapy (Waddington 2002). No such 
reviews have been undertaken in the field of drug treatment research, although there are a number of 
factors which argue for the particular importance of the therapeutic relationship for substance using 
clients.  
 
Perhaps the most important of these factors is the difficulty engaging and retaining drug using clients in 
treatment (Simpson, Joe, Rowan-Szal et al. 1997; Stanton 1997; Gossop et al. 1999; Joe, Simpson and 
Broome 1999). As discussed later, there are now first indications that a supportive therapeutic 
relationship may enhance such engagement and retention (Broome et al. 1999; Joe et al. 2001). 
Moreover, it has been suggested that the therapeutic relationship may serve as a model for improved 
relationships outside therapy (Greenson 1965; Henry and Strupp 1994) which in turn may improve 
outcomes. This is important since many drug using clients report unsatisfactory relationships with their 
social environment and a history of poor social and family relationships has been strongly implicated in 
the aetiology of drug use (Bell et al. 1996). Furthermore, the presence of a strong social network during 
and after treatment has been linked consistently to sustained improvements in drug use after treatment 
(Hser et al. 1999; Simpson et al. 2000; Broome et al. 2002).  
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It has been suggested that the nature of some drug treatment approaches which require the therapist to 
take an active educational and confrontational role may present challenges to developing a working 
therapeutic relationship (Millman 1986). Added to this, further relationship challenges arise since many 
clients deny the extent of the problem, are hostile towards the therapist or other clients, do not want to be 
in treatment and have a history of treatment failures (Joe et al. 1998).  
 
Aim of the review 
 
In the past two decades, a number of studies investigating the role of the therapeutic alliance in drug 
treatment have been published and thus it is timely that the findings of these studies are brought together 
in a comprehensive review. This paper has two principal aims: 1) to assess the degree to which the 
relationship between drug user and counsellor predicts the progress and outcomes of treatment and 2) to 
critically examine the evidence on which variables contribute to the development of a successful alliance.  
 
Method 
 
The review critically appraises the extent to which research efforts have identified predictors of successful 
therapeutic alliances and have evaluated the impact of the therapeutic alliance on drug treatment 
outcome. All peer reviewed research published in English during the past 20 years on these topics is 
considered. However, case studies and studies investigating the alliance in group or family treatment 
rather than individual treatment were excluded. The electronic databases Medline, PsycInfo and Ovid Full 
Text Mental Health Journals were searched using a list of relevant terms (see Table 1). Each search 
contained a minimum of one term from Area 1 and one term from Area 2. The bibliographies of relevant 
publications were studied to locate further literature. A meta-analytic approach was not adopted because 
the eighteen identified studies falling within the remit of this review varied widely with regard to 
therapeutic approach, methodological approach, definition of study outcomes, and the timing of 
assessments. Moreover, many studies did not include a quantifiable relationship between the alliance and 
outcome necessary for meta-analysis and this would have led to the exclusion of some of the most 
relevant studies. The purpose of the current review is to present a broad picture of the available evidence 
and also to highlight gaps in the knowledge that need to be addressed.  
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(insert Table 1 about here)  
 
 
The role of the alliance in predicting drug treatment outcomes 
 
The first part of the paper reviews studies investigating the relationship between the therapeutic alliance 
and treatment retention, engagement and outcomes in treatment (see Table 2).  
 
Retention. The question of whether better therapeutic alliances early in drug treatment predict longer 
treatment retention and completion has been addressed by a number of studies (Luborsky et al. 1995; Tunis 
et al. 1995; Belding et al. 1997; Carroll et al. 1997; Simpson, Joe, Rowan-Szal et al. 1997; Barber et al. 1999; 
De Weert-Van Oene et al. 1999; Petry and Bickel 1999; Barber et al. 2001; De Weert-Van Oene et al. 2001; 
Fenton et al. 2001). A common feature of these studies is that they measure the alliance early in treatment 
and only at one or two time points, which may not adequately reflect the changing nature of relationships. 
Few studies follow the course of the alliance throughout treatment, a point which will be highlighted later in 
this review. Where relationships were found they were mostly of a moderate effect size explaining around 5-
15% of the variance, which is comparable to the effect sizes found by meta-analysis investigating the 
alliance-outcome relationships (Horvath and Symonds 1991; Martin, Garske et al. 2000). However, apart 
from this, the studies vary greatly in methodological approach and analysis. There is some disagreement as 
to which rater perspective, which instrument, and which time point is the most predictive. Fenton et al. (2001) 
obtained client, counsellor and observer ratings of the alliance after the second therapy session using the 
Working Alliance Inventory (WAI). They found that only observer ratings, but not client and counsellor ratings, 
predicted retention in treatment. Barber et al. (1999), on the other hand, found that both client and therapist 
versions of the California Psychotherapy Alliance Scales (CALPAS) after the second session predicted 
retention. The latter study did not find this relationship for ratings after the fifth session and neither was there 
a relationship when using the Helping Alliance Questionnaire (HAq) after the second or fifth session, 
although, as discussed below, HAq and CALPAS fifth session scores were more predictive of actual 
treatment outcomes. In contrast, DeWeert et al. (1999; 2001) found that third session client ratings on the 
HAq of the alliance did predict retention in inpatient and outpatient treatment. Moreover, Petry & Bickel (1999) 
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also found a relationship between third session client and therapist ratings of the alliance and treatment 
completion. 
 
An interesting interaction of the alliance with psychiatric problems was also reported by Petry & Bickel (1999): 
Completion was predicted by an interaction between the therapist rated alliance and psychiatric severity. For 
clients with no or few psychiatric problems, the alliance was not related to treatment completion status. 
However, amongst those with moderate to severe psychiatric problems 75% of those with a good alliance but 
only 25% of those with a weak alliance completed treatment. It is not clear from the study whether high 
psychiatric severity clients who established good relationships with their therapists and those who did not 
differed according to the level of interpersonal behaviour problems. This interaction is a particularly important 
finding which warrants further investigation, as recent research has shown that the prevalence of dual 
diagnosis, ie concurrent diagnoses of drug dependence and psychiatric illness, is high (Marsden et al. 2000; 
Franken and Hendriks 2001; Virgo et al. 2001). An interaction of the alliance with treatment modality was 
reported by Barber et al. (2001). They found that retention was improved by a good alliance in drug 
counselling and psychodynamic treatment, but retention was worse for those with good relationships in 
cognitive therapy treatment. However, this study was the only one mentioning an effect of treatment 
philosophy, although there were several studies in similar settings (cf Table 2), thus the interpretation of this 
finding is difficult.  
 
In contrast to the previously mentioned studies, two studies failed to find a significant relationship between 
the alliance and retention (Tunis, Delucchi et al. 1995; Belding, Iguchi et al. 1997). Both studies assessed the 
alliance at a later stage in treatment (after months 1 and 3, or months 4 and 6, respectively), and included 
only clients retained beyond these points. The problem with this approach is that the failure to build a strong 
alliance early on in treatment may be partly responsible for the typically large dropout rates in the first few 
months. It is thus possible that clients with less optimal alliances may have left by the time the alliance and 
retention were assessed for the first time, and that the alliance is less important for retention in later stages of 
treatment. However, the studies also had small sample sizes of n<50 and thus lacked the power to find small 
effects. In contrast, Simpson et al. (1997) found a small but significant relationship between the late alliance 
(week 8) and retention for clients staying beyond the third month, but their study had much greater power to 
detect such small effects (n>500). 
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It is difficult to say exactly under which circumstances the alliance predicts retention. This is due firstly to the 
methodological problems of the studies that did not find a alliance-retention relationship and secondly the 
considerable differences in sample, setting, design, and analytical methods in studies that found 
relationships, but not for all rater/assessment point/instrument combinations. The relationship between the 
early alliance and retention in drug treatment appears a broadly consistent finding, which appears largely 
independent of measurement approach, as there are studies for each instrument and rater perspective 
combination that found a relationship between the alliance and retention. This is in contrast to findings in the 
psychotherapy field that the therapist rated alliance is less predictive of outcome than client alliance ratings 
(Horvath and Symonds 1991). 
 
Further research should address the open methodological questions of alliance measurement highlighted in 
this review, for example why in some studies certain instruments fail to show a relationship with outcome, 
whether and why different raters have different views of the alliance, and whether clients, therapists or 
observers make the more predictive ratings. It is important that potential moderators of the alliance-outcome 
relationship are investigated further, as studies looking specifically at such effects have found interactions of 
the alliance with treatment and client factors (Hser, Grella et al. 1999; Petry and Bickel 1999; Barber, 
Luborsky et al. 2001). Research is also needed on the alliance later in treatment and on whether the course 
of the alliance over time is associated with retention in drug treatment. 
 
Engagement in treatment. A consistent finding in the drug treatment literature is that successful 
engagement of clients in the treatment process predicts positive treatment outcomes over and above 
other client factors (Simpson et al. 1995; Simpson, Joe and Rowan-Szal 1997; Fiorentine 1998; Joe, 
Simpson and Broome 1999; Joe, Simpson, Greener et al. 1999). Several of the early alliance theorists 
have suggested that a positive early alliance is desirable or even essential for clients to become engaged 
in treatment (Greenson 1965; Strupp 1969; Luborsky, Barber et al. 1995). To date, there are only a 
handful of studies on the effect of the therapeutic relationship on client engagement in drug treatment, 
and some of these studies have employed unvalidated measures consisting of only a few items to 
capture the quality of the relationship.  
 
 8
Nevertheless, three studies reported positive association between good therapeutic relationships and 
treatment engagement (Connors et al. 1997; Simpson, Joe, Rowan-Szal et al. 1997; Fiorentine et al. 
1999), whereas only one found no association (Tunis, Delucchi et al. 1995), see Table 2. Fiorentine and 
colleagues (1999) examined predictors of client engagement, operationalised as the product of session 
attendance and weeks retained in outpatient drug free counselling treatment. The client-reported alliance 
was measured only once at eight months using four items concerned with counsellor caring and 
helpfulness. For women, all items were related to treatment engagement, but the strongest association 
was with counsellor caring. For men, helpfulness was related to engagement, but caring was not. This 
finding could suggest subtle alliance differences between women and men; women may respond better to 
an empathic counselling style whereas men may respond to a more utilitarian style. However, due to the 
timing of the client-counsellor relationship assessment it is impossible to determine whether clients who 
are easily engaged establish better relationships or whether, as the author suggests, good relationships 
lead to better engagement. No relationship was found between the alliance late in treatment and 
concurrent treatment participation (Tunis et al 1995). However, clients were included only if they had 
remained in treatment for at least three month and it is thus possible that any influence of the alliance on 
participation might already have led clients to disengage by the time the study started. Simpson and 
colleagues (1997) found that counsellor rated “rapport” at two months into treatment was positively 
related to concurrent session attendance in clients who were retained in treatment. However, as in Tunis 
et al.’s study, clients who dropped out before the third month were excluded. Those who were particularly 
difficult to engage early on, and so could have been the focus of engagement research were thus not 
considered adequately in any of the three studies. A notable exception is a prospective alcohol treatment 
study, in which there was a positive relationship between the alliance early in treatment and later 
attendance and participation in treatment (Connors, Carroll et al. 1997). 
 
(insert Table 2 about here) 
Drug use outcomes. Inconsistent results have been reported with regard to the relationship of alliance 
and treatment outcomes over and above the effect of retention. Several studies reported no relationship 
between the client or counsellor rated early alliance and in-treatment or post-treatment drug use in 
outpatients (Belding, Iguchi et al. 1997; Barber, Luborsky et al. 2001). In contrast, other outpatient studies 
found that counsellor rated rapport averaged across treatment predicted various post-treatment drug use 
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outcomes (Joe, Simpson et al. 2001), and counsellor rated rapport in months 1 and 2 predicted lower 
levels of subsequent in-treatment drug use in months 2 and 3 (Simpson, Joe, Rowan-Szal et al. 1997). 
Inconsistent findings were also reported by Fenton et al. (2001) and Hser et al. (1999). Fenton et al. 
reported that the third session alliance predicted in-treatment abstinence during outpatient drug free 
treatment if assessed by an observer, not if rated by therapist or client. Hser et al.’s study compared 
different treatment settings and found that the early client rated alliance strongly predicted 12-month post-
treatment abstinence in residential treatment settings, but not, as in Fenton et al.’s study, in outpatient 
settings (Hser, Grella et al. 1999). Later (3rd month) alliance ratings by clients were related to concurrent 
and later assessments of improvement in drug use outcome, although not if controlled for earlier 
improvements.  
 
Only weak and difficult to interpret relationships between the alliance on one hand and drug use and 
psychiatric outcomes on the other were found amongst cocaine users in a six-month outpatient 
programme of drug treatment (Barber, Luborsky et al. 1999). Results were similar for completers and 
non-completers, with slightly stronger alliance-outcome relationships found for completers. Session 5 
alliance measurements with the HAq were weakly associated with in-treatment drug use at one month 
(probably concurrent measurement), but not at 6 months. Session 2 alliance assessments and 
assessments using the CALPAS did not show relationships with drug use outcomes. Relationships were 
also only found for client but not for therapist ratings. The authors pointed out that there was limited 
variability in the alliance scores of both clients and therapists, which could have influenced the chance of 
finding positive relationships. 
 
There are few firm conclusions that can be drawn from these contradictory results. It appears that the 
alliance measured early on (sessions 2 and 3) is an inconsistent predictor of post-treatment outcomes, 
but may influence how clients progress early in treatment. The alliance predicted long term drug use 
outcome in only one study, although with N=789 this study was one of the largest studies reviewed (Hser, 
Grella et al. 1999). Temporally closer alliance and outcome measures were generally more strongly 
related, as findings were that the alliance after the first month and alliance scores averaged across 
treatment were related to concurrent and later drug use improvements. It has been suggested that the 
alliance measured later on could be an indicator of good treatment progress and client satisfaction rather 
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than a predictor of positive outcomes (Belding, Iguchi et al. 1997). Rater perspective, alliance instrument 
and treatment setting may play a role, but further investigation would be needed to clarify the exact nature 
of the relationships. 
 
Other treatment outcomes: Little attention has been paid to whether the strength of the alliance influences 
clients’ various other problem areas such as criminal justice involvement, their social relationships and 
support networks or their health. Two studies report on the effect of the alliance on 
psychological/psychiatric symptoms. The client rated alliance at sessions 2 and 5, interacting with 
retention, predicted improvements of depressive symptoms, but not overall psychiatric severity, at one 
and six months in treatment (Barber, Luborsky et al. 1999). Therapist ratings were unrelated to 
psychiatric outcomes. Belding et al. (1997) reported no relationship between the early client and therapist 
rated alliance and improvements in psychological problems. A fourth study used an outcome measure 
computed from existing scales of another instrument, namely self esteem minus anxiety and depression 
scores, which they called psychological functioning (Bell et al. 1997). It is not clear how the authors 
justified this and no validation of this new scale was reported. The alliance was measured after intake, at 
2 weeks and 4 weeks, using a 6-item instrument developed by the authors to capture therapeutic 
connection. Little further information about this instrument was provided, apart from a satisfactory internal 
consistency. The authors reported a relationship between the alliance and a change in psychological 
functioning but did not specify at which point the alliance was measured. Higher counselling rapport 
averaged across treatment predicted lower post-treatment illegal activity and arrests, even when 
controlled for treatment retention and satisfaction (Joe, Simpson et al. 2001). 
 
Client, therapist and treatment predictors of the quality of the therapeutic relationship 
 
The second aim of the paper was to review studies on determinants of the therapeutic alliance, an area in 
which there has been far less research to date than on the alliance-outcome relationship. The evidence 
on client determinants, therapist determinants and treatment setting determinants of the alliance  is 
presented in turn (see Table 3).  
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Client predictors. A large number of studies have examined client pre-treatment characteristics that may 
be associated with the development of the therapeutic relationship. Overall, research has failed to find 
any relationship with client demographic variables. No associations were found with gender (Luborsky et 
al. 1996; Belding, Iguchi et al. 1997; De Weert-Van Oene, De Jong et al. 1999), age (Luborsky, Barber et 
al. 1996; Belding, Iguchi et al. 1997; De Weert-Van Oene, De Jong et al. 1999), race (Luborsky, Barber et 
al. 1996; Belding, Iguchi et al. 1997; Connors et al. 2000), marital status or employment (Luborsky, 
Barber et al. 1996; Belding, Iguchi et al. 1997). Connors et al. (2000) found a small relationship between 
female client gender and positive therapist rated early alliance, but not client rated alliance. 
 
Neither were diagnostic variables such as drug use (Luborsky, Barber et al. 1996; Belding, Iguchi et al. 
1997; Barber, Luborsky et al. 1999; De Weert-Van Oene, De Jong et al. 1999; Connors, DiClemente et al. 
2000), psychological symptoms or psychiatric severity predictive of the early alliance (Luborsky, Barber et 
al. 1996; Belding, Iguchi et al. 1997; Barber, Luborsky et al. 1999; De Weert-Van Oene, De Jong et al. 
1999). This appears independent of the instruments used in assessing alliance and predictors.    
 
Client predictors for the early alliance tended to be either related to experiences in previous treatment 
attempts (De Weert-Van Oene, De Jong et al. 1999) or related to motivation or readiness for treatment 
(Joe, Simpson et al. 1998; Connors, DiClemente et al. 2000). DeWeert et al. (1999) found relationships 
between the early alliance and the number of previous treatment episodes, with clients with more 
previous treatment scoring lower on the HAq Helpfulness subscale, but clients with previously completed 
treatment episodes scored higher on the Cooperation subscale. Joe et al. (1998) reported that pre-
treatment motivation is a good predictor of client-counsellor rapport at one and three months in residential 
and outpatient drug free sample, but no relationship was found for methadone maintenance clients.  
 
(insert Table 3 about here) 
 
Therapist predictors. Only one study examined therapist characteristics as predictors of the alliance in 
substance misuse treatment. No relationship was found between client or therapist ratings of the alliance 
and therapist age, gender or education (Connors, DiClemente et al. 2000). 
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Treatment modality. Although this was not one of their research questions, Crits-Christoph et al. (1999) 
found that treatment modality (individual drug counselling, cognitive therapy or psychodynamic 
counselling) was unrelated to the client or therapist reported alliance in the 2nd and 5th sessions.   
 
Discussion 
 
A key conclusion from this review is that early therapeutic alliance appears to be a consistent predictor of 
engagement and retention in drug treatment. Although the strength of the relationship of the alliance to 
retention and engagement in the reviewed studies was typically of moderate size (correlations were 
typically between r=0.15 and r=0.30), it appeared to be robust in so far as only two studies did not find 
such a relationship, and these studies had significant methodological problems including small sample 
sizes. There is some evidence that a good therapeutic relationship may be especially important in 
retaining drug using clients with psychiatric co-morbidity. With regard to other treatment outcomes, there 
are indications that early alliance may influence early improvements in treatment, but that it is an 
inconsistent predictor of post-treatment outcomes. Temporally closer alliance and outcome measures 
were more strongly related, and findings indicated that alliance measured after the first month and 
alliance scores averaged across treatment were related to concurrent and later drug use improvements. 
This review appears to confirm for drug treatment previous findings in psychotherapy research of the 
importance of the alliance in predicting treatment outcome, despite the fact that the outcomes studied in 
drug treatment research differed from those relevant to psychotherapy. This is an important result, as 
there are several characteristics of drug treatment that make it different from psychotherapy in general. 
For example, depending on the treatment setting it may be the therapist who effectively deprives the 
patient of his primary substance and this might have been expected to lead to tensions in the early 
relationship. In contrast, in psychotherapy the therapist might be more readily seen as a helping figure. 
However, in drug treatment, as in psychotherapy, evidence was found that the early therapeutic alliance 
is predictive of outcome and the size of the relationships reported are similar to those reported for the 
psychotherapy field (Horvath and Symonds 1991; Martin, Garske et al. 2000). 
 
A major difficulty in interpreting studies in this area regards whether there is enough evidence that 
alliance has a causal impact on the outcome of therapy, or whether the association between the alliance 
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and outcome is spurious or even runs in the opposite direction with changes in symptoms influencing 
alliance. To date, this key question has not been addressed within the field of substance misuse 
research; however, there are two studies from the broader psychotherapy field that shed light on this 
issue and may provide pointers for the design of studies in drug treatment. Barber et al. (2000) 
investigated the causal relationship between alliance and depression outcome in a small sample of 
patients with generalised anxiety disorder, depression or personality disorder by assessing and 
controlling for early symptomatic improvements in levels of depression. The authors found that alliance 
predicted later depression outcome over and above early symptom improvement. Similarly, Klein et al 
(2003) investigated the relationship between the alliance and subsequent change in symptomatology in a 
large sample of chronically depressed patients controlling for two potential sources of spuriousness: a) 
early change in symptoms which may influence both alliance and subsequent change in symptoms and b) 
characteristics that may contribute to both poor alliance and poor outcome. Consistent with Barber et al.’s 
finding, early alliance predicted subsequent change even after controlling for prior and current symptom 
levels and a number of possible confounders including gender, chronicity of depression, and personality 
disorders. Such an approach of controlling for early improvements to measure the relationship between 
symptom change and alliance might be difficult to realise in many drug treatment studies, as the main 
outcomes of interest are usually not symptomatic improvements, but retention, compliance or post-
treatment abstinence for which there is not baseline score. However an important early control variable 
might be whether the client actually feels that the treatment is helpful.    
 
A second major conclusion of the review is that clients’ demographic or diagnostic pre-treatment 
characteristics, as well as therapist age and gender, do not appear to play an important role in the 
prediction of the quality of the therapeutic alliance, although these findings have to be regarded as 
preliminary until more studies on the determinants of the alliance in drug treatment become available. 
Modest consistent relationships were reported for dynamic variables such as motivation, treatment 
readiness and positive previous treatment experiences. This is encouraging as, unlike demographic 
variables, these are variables that can be influenced by skilful treatment providers. In this context, 
motivational interviewing is just one technique that has been successfully used in recent years. One of 
the key assumptions in the use of motivational interviewing for facilitating change in substance use is that 
the therapeutic relationship is of crucial importance as the motivational state of the client can be 
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substantially influenced by a counselling style characterised by empathy and support of client autonomy. 
Miller and Rollnick asserted that “motivation for change can not only be influence by but in a very real 
sense arise from an interpersonal context” (Miller and Rollnick 2002, page 22).  
 
We must conclude that a large proportion of the variability in therapeutic alliance remains unexplained. 
Studies in generic counselling and psychotherapy settings have identified additional predictors that have 
not yet been included in studies with drug using clients, the most important one being the quality of past 
and present social relationships (Moras and Strupp 1982; Gelso and Carter 1985; Kokotovic and Tracey 
1990; Mallinckrodt 1995; Eames and Roth 2000; Kanninen et al. 2000; Mallinckrodt 2000). The findings of 
these studies consistently suggest that clients with more successful relationship histories, secure 
attachment style and better social support find it easier to establish a successful alliance with their 
therapists, which in turn is likely to have positive effects on retention and outcome. Other factors that 
have not yet been investigated concern client-counsellor matching. Research questions that future 
studies need to address include whether the process of allocation of therapists to clients (agency 
allocation, therapist choice of clients or client choice of therapist) or gender matching influences the 
alliance.  
 
Further investigations are also needed to examine the course of the relationship over time and whether 
the course of the alliance plays a role in predicting drug treatment retention and outcome. Another area 
that deserves attention is the identification of moderators of the alliance-outcome relationship as studies 
looking specifically at such effects have found interactions of the alliance with treatment and client factors 
(Hser, Grella et al. 1999; Petry and Bickel 1999; Barber, Luborsky et al. 2001). The treatment setting and 
treatment philosophy may determine how much of a role the therapeutic relationship plays in explaining 
treatment retention and outcomes, but further investigation is needed to clarify the exact nature of the 
relationships. For this reason, future studies should pay special attention to include clear descriptions of 
treatment sample, treatment method as well as treatment philosophy, which are lacking in many current 
studies in the field of substance misuse treatment.  
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Tables 
 
 
Table 1. List of search terms: the therapeutic alliance in drug treatment 
Area 1 
Therapeutic alliance 
Helping alliance 
Working alliance 
Therapeutic relationship 
Therapy relationship 
Counselling/counseling relationship 
Working relationship 
Client and counsellor/counselor and relationship 
Client and therapist and relationship 
Patient and counsellor/counselor and relationship 
Patient and therapist and relationship 
Rapport and counselling/counselling  
 
Area 2 
Substance (use or user or misuse or abuse or dependency or dependence) 
Drug (use or user or misuse or abuse or dependency or dependence) 
Heroin  
Methadone  
Cocaine 
Crack  
Stimulant  
Narcotics 
Addiction 
Addictive  
 
 
 
Table 2. Studies investigating the relationship between alliance and different drug treatment outcomes 
Outcome Authors Alliance Measure Assessment point Effects Sample Treatment 
Retention       
Time in treatment Barber et al. 1999 HAq-II –P, HAq-II-T 
CALPAS-P, CALPAS-T 
Sessions 2 & 5 CALPAS-P and -T at Session 2 but not 
Session 5 predicted retention  
252 cocaine users  O/p IDC, DYN, CT 
Time in treatment Barber et al. 2001 HAq-II –P, CALPAS-P Sessions 2 & 5 CALPAS-P & -T at Session 2. Interaction 
with modality: Positive: IDC and DYN, 
negative: CT 
308 cocaine users  O/p, IDC, DYN, CT 
Time in treatment Carroll et al. 1997 VTAS-O Session 2 TA predicts retention in clinical 
management but not CT 
103 cocaine users with 
dual diagnosis 
O/p CT and clinical 
management 
Time in treatment DeWeert-Van Oene 
et al. 1999 
HAq-I-P n=260 early, n=80 
late alliance 
Retention predicted by “Helpfulness” scale 340, drug & alcohol 
users 
I/p and ODF 
Time in treatment DeWeert-Van Oene 
et al. 2001 
HAq-I-P 3rd week Explained 8% when controlled for intake  93 alcohol & drug users I/p 
Time in treatment Fenton et al. 2001 WAI-O, -T and –C 
HARS-O,CALPAS-O, 
VTAS-O 
2nd Session Observer ratings predict retention, but client 
or counsellor ratings do not 
46 cocaine users with 
comorbid alcohol use 
O/p psychotherapy 
Completion Petry & Bickel 1999 HAq-II-P, HAq-II-T For n=46 3rd 
Session, rest after 
treatment 
Completers had higher scores for T and P 
version 
114 opiate users Buprenorphine & 
counselling 
Completion Petry & Bickel 1999 HAq-II-P, HAq-II-T For n=46, 3rd 
Session, rest after 
treatment  
T predicted retention in interaction with 
psychiatric severity. Main effect not sign. 
114 opiate users Buprenorphine & 
counselling 
Time in treatment Simpson et al. 
1997 
T-rated “rapport” At 8 weeks Positive correlation. Clients included if 
retained for 3 months 
517 opiate user O/p MM 
Time in treatment Belding et al. 1997 HAq-II-P, HAq-II-T 1 & 3 months None 57 decreasing to 42  O/p 
Completion Tunis et al. 1995 CALPAS-P 4-6 months None 41 decreasing to 20 O/p MM then detox 
Engagement   
Treatment 
commitment  
Broome, Simpson 
et al. 1999 
P-rated, 5-items 
measuring “rapport” 
1st month Alliance predicted 3 month-outcome in RR, 
ODF & MM. Included those retained for 
3 months. 
1141 cocaine users 
(RR) & 718 (ODF), 689 
opiate users (MM)  
RR, ODF, o/p MM 
Participation Connors et al. 1997 WAI-P, WAI-T After Session 2 Alliance predicted participation in o/p 
treatment, but not aftercare 
698 alcohol o/p, 498 
alcohol aftercare o/p 
O/p alcohol 
counselling 
Engagement  Fiorentine et al. 
1999 
P-rated, 3 items 8 months for retai-
ned/non-retained 
Better alliance predicted better engagement 302 mainly stimulant 
users 
O/p IDC 
Participation Tunis et al. 1995 CALPAS-P 4-6 months  None 41 decreasing to 20 O/p MM then detox 
                          (cont.) 
Key: o/p=outpatient, i/p=inpatient, RR=residential rehabilitation, DC=day care, MM=methadone maintenance, IDC=drug counselling, DYN=dynamic therapy, CT= cognitive or 
cognitive behaviour therapy, o/c=outcome. Instruments: –T=Therapist version, -P patient version, -O=observer version 
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Table 2. Studies investigating the relationship between the alliance and drug treatment outcome (continued) 
Outcome Authors Alliance Measure Assessment point Effects Sample Treatment 
Psychiatric well-being  
Psychiatric o/c Barber et al. 
1999 
HAq-II –P, HAq-II-T 
CALPAS-P, CALPAS-T 
Sessions 2 & 5 HAq-II-P predicted depression o/c  
 
252 cocaine users  O/p IDC, DYN, CT 
Psychological 
functioning 
Bell et al. 1997 P-rated, unvalidated 6-
items, “connectedness” 
1st, 2nd and 4th 
week  
Effects found, but not specified at which time 
relationships were found 
139 drug users 28-day RR, 28-day-
DC 
Psychiatric o/c Belding et al. 
1997 
HAq-II-P, HAq-II-T 1 & 3 months 
 
None 57 at 1 month, 42 at 3 
month 
O/p 
Drug use outcomes      
Drug use at 3 & 6 
months 
Belding et al. 
1997 
HAq-II-P, HAq-II-T 1 & 3 months Alliance at 3 months predicted later drug o/c, 
early alliance does not 
57 at 1 month, 42 at 3 
month 
O/p  
Post-treatment 
drinking o/c 
Connors et al. 
1997 
WAI-P, WAI-T After Session 2 Alliance predicted post-treatment drinking 
outcome 
698 alcohol o/p, 498 
alcohol aftercare o/p 
O/p alcohol 
counselling 
Post-treatment 
abstinence 
Hser et al. 1999 P-rated, 5-items, 
measuring “rapport” 
1st month MM: better alliance=worse outcomes (but 
interaction: previous treatment with low rapport 
worst o/c, experienced with high rapport best 
o/c), in ODF&RR: better alliance=better o/c 
789 cocaine users O/p MM, long term 
and short term RR, 
ODF 
Drug use Barber et al. 
1999 
HAq-II –P, HAq-II-T 
CALPAS-P, CALPAS-T 
Sessions 2 & 5 None 
 
252 cocaine users  O/p IDC, DYN, CT 
Other outcomes      
Various o/c Fenton et al. 
2001 
WAI-T, WAI-P, WAI-O, 
VPPS-O, CALPAS-O, 
HA Rating Scale-O 
3rd Session Outcomes predicted by observer measures, 
not by WAI-P and WAI-T 
46 cocaine users (of 90: 
44 not used because of 
dropout) 
O/p CT, IDC 
Various post-
treatment o/c 
Joe et al. 2001 T-rated instrument 
measuring “rapport” 
Averaged over 
treatment (up to 6 
measurements) 
Alliance predicted drug o/c and criminality Two cohorts: 354 and 
223  
O/p MM & IDC 
Various o/c Luborsky et al. 
1985 
HAq-I 3rd Session Alliance predicted outcomes Opiate users O/p MM & DYN, 
CT, IDC 
Key: o/p=outpatient, i/p=inpatient, RR=residential rehabilitation, DC=day care, MM=methadone maintenance, IDC=drug counselling, DYN=dynamic therapy, CT= cognitive or 
cognitive behaviour therapy, o/c=outcome. Instruments: –T=Therapist version, -P patient version, -O=observer version 
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Table 3. Studies investigating the relationship between the alliance and client and therapist characteristics 
Predictor Authors Alliance Measure Assessment time point Effects Sample Treatment 
Client predictors  
Age Connors et al. 
2000 
WAI-T, WAI-P Session 2 In o/p sample & WAI-C only, significant 
positive predictor of o/p P-alliance in 
multivariate analysis 
707 o/p, 480 a/c O/p and a/c alcohol, 
CT, MET, TSF 
Age Petry & Bickel 
1999 
HAq-II-P, HAq-II-T For n=46: 3rd Session, 
for rest after treatment  
None 114 opiate users Buprenorphine & 
counselling, o/p 
Gender Connors et al. 
2000 
WAI-T, WAI-P Session 2 WAI-T higher for o/p females, but n.s. in 
multivariate analysis in a/c sample 
707 o/p, 480 a/c O/p and a/c alcohol, 
CT, MET, TSF 
Gender Belding et al. 1997 HAq-II-P, HAq-II-T 1 & 3 months None 57 decreasing to 
42  
O/p 
Gender  DeWeert-Van 
Oene et al. 1999 
HAq-I-P For n=260 early alliance, 
for 80 at 25 weeks 
None 340 drug & alcohol 
users 
I/p and ODF 
Gender Luborsky et al. 
1996 
HAq-II-P, HAq-II-T 
CALPAS-P, CALPAS-T 
Sessions 2 & 5 None 246 cocaine users DYN, CT, IDC, group 
counselling 
Gender Petry & Bickel 
1999 
HAq-II-P, HAq-II-T For n=46: 3rd Session, 
for rest after treatment  
None 114 opiate users  Buprenorphine & 
counselling, o/p 
Ethnicity Belding et al. 1997 HAq-II-P, HAq-II-T 1 & 3 months None 57 decreasing to 
42  
O/p 
Ethnicity  Connors et al. 
2000 
WAI-T, WAI-P Session 2 None 707 o/p, 480 a/c O/p and a/c alcohol, 
CT, MET, TSF 
Ethnicity Luborsky et al. 
1996 
HAq-II-P, HAq-II-T 
CALPAS-P, CALPAS-T 
Sessions 2 & 5 None 246 cocaine users DYN, CT, IDC, group 
counselling 
Education Connors et al. 
2000 
WAI-T, WAI-P Session 2 Negatively predicted o/p P scores in 
multivariate analysis 
707 o/p, 480 a/c O/p and a/c alcohol, 
CT, MET, TSF 
Previous 
treatment  
DeWeert-Van 
Oene et al. 1999 
HAq-I-P For n=260 early alliance, 
for 80 at 25 weeks 
Previous treatment completed – better 
alliance, not-completed – worse alliance 
340 drug & alcohol 
users 
I/p and ODF 
Severity of 
drinking 
Connors et al. 
2000 
WAI-T, WAI-P Session 2 Negatively associated with T score, n.s. in 
multivariate analysis 
707 o/p, 480 a/c O/p and a/c alcohol, 
CT, MET, TSF 
Pattern/severity 
of drug use 
Barber et al. 1999 HAq-II-P, HAq-II-T, 
CALPAS-P, CALPAS-T 
Sessions 2 & 5 None 252 cocaine users O/p IDC, DYN, CT 
Drug use Luborsky et al. 
1996 
HAq-II-P, HAq-II-T 
CALPAS-P, CALPAS-T 
Sessions 2 & 5 None 246 cocaine users DYN, CT, IDC, group 
counselling 
                          (cont.) 
Key: o/p=outpatient, i/p=inpatient, a/c=after care. CT= cognitive or cognitive behaviour therapy, DC=day care, DYN=dynamic therapy, IDC=drug counselling, MM=methadone 
maintenance, ODF: outpatient drug free counselling, RR=residential rehabilitation, TSF=12-step programme, MET: Motivational Enhancement Therapy. Instruments: –
T=Therapist version, -P patient version, -O=observer version, n.s.=not significant.  
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Table 3. Studies investigating the relationship between client and therapist characteristics at intake and the alliance (continued) 
Predictor Authors Alliance Measure Assessment time point Effects Sample Treatment 
Depression Connors et al. 
2000 
WAI-T, WAI-P Session 2 Positively predicted a/c P score in 
multivariate analysis, correlated but n.s. in 
multivariate analysis in o/p sample 
707 o/p, 480 a/c O/p and a/c alcohol, 
CT, MET, TSF 
Psychiatric 
severity  
Barber et al. 1999 HAq-II-P, Haq-II-T, 
CALPAS-P, CALPAS-T 
Sessions 2 & 5 None 252 cocaine users O/p IDC, DYN, CT 
Psychiatric 
severity 
Belding et al. 1997 HAq-II-P, HAq-II-T 1 & 3 months None 57 decreasing to 
42  
O/p 
Psychiatric 
severity  
DeWeert-Van 
Oene et al. 1999 
HAq-I-P For n=260 early alliance, 
for 80 at 25 weeks 
None 340 drug & alcohol 
users 
I/p and ODF 
Psychiatric 
severity 
Luborsky et al. 
1996 
HAq-II-P, HAq-II-T 
CALPAS-P, CALPAS-T 
Sessions 2 & 5 None 246 cocaine users DYN, CT, IDC, group 
counselling 
Social 
support 
Connors et al. 
2000 
WAI-T 
WAI-P 
Session 2 Correlated with P scores, n.s. in 
multivariate analysis. 
707 o/p, 480 a/c O/p and a/c alcohol, 
CT, MET, TSF 
Treatment 
readiness 
Connors et al. 
2000 
WAI-T, WAI-P Session 2 Treatment readiness predicted WAI-P in 
multivariate analysis, not WAI-T 
707 o/p, 480 a/c O/p and a/c alcohol, 
CT, MET, TSF 
Treatment 
readiness 
Joe et al. 1998 P-rated instrument 
measuring “rapport” 
1 & 3 months In RR and ODF treatment readiness 
predicted alliance, but not in MM 
2265 RR, 1791 
ODF, 981 MM 
RR, o/p MM, ODF 
      
Therapist predictors      
Age Connors et al. 
2000 
WAI-T, WAI-P Session 2 Correlated with o/p P scores only, n.s. in 
multivariate analysis 
707 o/p, 480 a/c O/p and a/c alcohol, 
CT, MET, TSF 
Gender Connors et al. 
2000 
WAI-T, WAI-P Session 2 None 707 o/p, 480 a/c O/p and a/c alcohol, 
CT, MET, TSF 
Education Connors et al. 
2000 
WAI-T, WAI-P Session 2 Correlated with a/c T scores only, n.s. in 
multivariate analysis 
707 o/p, 480 a/c O/p and a/c alcohol, 
CT, MET, TSF 
       
Key: o/p=outpatient, i/p=inpatient, a/c=after care. CT= cognitive or cognitive behaviour therapy, DC=day care, DYN=dynamic therapy, IDC=drug counselling, MM=methadone 
maintenance, ODF: outpatient drug free counselling, RR=residential rehabilitation, TSF=12-step programme, MET: Motivational Enhancement Therapy. Instruments: –
T=Therapist version, -P patient version, -O=observer version, n.s.=not significant 
 
